PhoreMost Overview

Founded 2014
Status Private
Latest Deal Type Series A
Latest Deal Amount $15.5M
Latest Deal Amount
Investors 10

PhoreMost General Information


Developer of a next-generation phenotypic screening platform called to identify the best new targets for future therapy, and crucially, how to drug them. The company's platform can systematically unmask hidden, or cryptic druggable sites in the human genome and directly link them to useful therapeutic functions in a live-cell context. Its platform uses these functionally validated protein fragments to then rapidly inform the design of small molecule drugs with the same shape, providing a continuous pipeline of highly validated first-in-class drug discovery programmes for out-licensing to Pharma.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Discovery Tools (Healthcare)
Primary Office
  • Office 2055, Building 250
  • Babraham Research Campus, Cambridgeshire
  • Cambridge CB22 3AT
  • England, United Kingdom
+44 01223 000000

PhoreMost Timeline

Financing Round
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

PhoreMost Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Early Stage VC (Series A) 30-Apr-2018 $15.5M 000.00 Completed Product Development
4. Grant 27-Apr-2018 00.000 Completed Product Development
3. Grant 15-Jun-2017 00.000 Completed Product Development
2. Grant 13-May-2015 $2.14M $6.12M Completed Startup
1. Seed Round 11-Mar-2015 $6.12M $6.12M Completed Startup

PhoreMost Competitors (24)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing
Aviva Systems Biology Corporation San Diego, CA 0
0000 00000000000 Private Equity-Backed Cambridgeshire, United Kingdom 00 00.000 0000000 0000 00.000
000000 000000 Venture Capital-Backed South San Francisco, CA 0 000.00 00000000000 000.00
000000000 00000000 Venture Capital-Backed Cambridge, United Kingdom 00 00000 00000000000 00000
0000000 Venture Capital-Backed San Diego, CA 00 000.00 0000000000 0 000.00

PhoreMost Executive Team (7)

Name Title Board Seat Contact Info
Christopher Torrance Ph.D Co-Founder, Board Member & Chief Executive Officer
Markus Muellner Ph.D Chief Technology Officer
Grahame McKenzie Ph.D Co-Founder & Chief Scientific Officer
Ashok Venkitaraman Ph.D Co-Founder & Company Director
Charli Batley Ph.D Director, Operations

1 Former Executive

PhoreMost Board Members (4)

Name Representing Role Since
Christopher Torrance Ph.D PhoreMost Co-Founder, Board Member & Chief Executive Officer 000 0000
Gerald Chan Ph.D Morningside Group Board Member 000 0000
Hermann Hauser Ph.D Amadeus Capital Partners Board Member 000 0000
Jonathan Milner Ph.D Self Chairman & Company Director 000 0000

PhoreMost Investors (10)

To view PhoreMost‘s full investor history, request access »
Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Morningside Group Venture Capital Minority 000 0000 000000 0
Innovate UK Government Minority 000 0000 000000 0
Amadeus Capital Partners Venture Capital Minority 000 0000 000000 0
Cambridge Angels Angel Group Minority 000 0000 000000 0
Cambridge Enterprise Angel Group Minority 000 0000 000000 0

Ready to get started?

Request a free trial